| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.55 | 0.04 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.37 | 0.008 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.23 | 0.08 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.005 |